Summary: Rehabilitation in the Setting of Untreated Cancer-Associated Acute Deep Vein Thrombosis.

Summary: Tumor Flare Reaction in a Classic Hodgkin Lymphoma Patient Treated With Brentuximab Vedotin and Tislelizumab: A Case Report.

Summary: Advanced stages of classical Hodgkin lymphoma - first-line treatment options.

Summary: Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial.

Summary: Anti-Angiogenic Agent Combined with Anti-PD-1 Immunotherapy Showed Activity in Patients With Classical Hodgkin Lymphoma Who Have Failed Immunotherapy: A Retrospective Case Report Study.

Summary: Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes.

Summary: Double-refractory Hodgkin lymphoma: tackling relapse after brentuximab vedotin and checkpoint inhibitors.

Summary: Controversies in the management of early-stage Hodgkin lymphoma.

Summary: How to choose first salvage therapy in Hodgkin lymphoma: traditional chemotherapy vs novel agents.

Summary: Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana.

Summary: Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab.

Summary: Novel Adenosine Deaminase 2 (ADA2) Mutations Associated With Hematological Manifestations.